Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z2UW
|
||||
Former ID |
DIB012160
|
||||
Drug Name |
Nicaraven
|
||||
Synonyms |
AVS; Antevan; Antevas
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cerebrovascular disorders [ICD10:I60-I69] | Phase 3 | [528516] | ||
Company |
Chugai Pharmaceutical
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H16N4O2
|
||||
Canonical SMILES |
C(=O)(c1cnccc1)NC(CNC(=O)c1cnccc1)C
|
||||
CAS Number |
CAS 79455-30-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Poly [ADP-ribose] polymerase-1 | Target Info | Modulator | [528516] | |
KEGG Pathway | Base excision repair | ||||
NF-kappa B signaling pathway | |||||
PANTHER Pathway | FAS signaling pathway | ||||
Pathway Interaction Database | Integrin-linked kinase signaling | ||||
Caspase Cascade in Apoptosis | |||||
Notch-mediated HES/HEY network | |||||
Reactome | Dual Incision in GG-NER | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.